What types of agencies buy Drug Evaluation services?

Federal agencies across all departments procure Drug Evaluation services, including the Department of Defense, Department of Veterans Affairs, General Services Administration, and civilian agencies. State and local governments also issue Drug Evaluation contracts through their own procurement portals.

How do I find Drug Evaluation contracts with SamSearch?

Use SamSearch to browse pre-classified opportunities in one place, with AI-powered filtering by agency, set-aside, and deadline.

Are there set-aside contracts for small businesses in Drug Evaluation?

Yes. Many Drug Evaluation contracts are set aside for small businesses, including 8(a), WOSB, SDVOSB, and HUBZone firms. Use SamSearch's set-aside filters to find contracts your business qualifies for.

How competitive are Drug Evaluation government contracts?

Competition varies by contract size and type. Large IDIQ vehicles in Drug Evaluation can attract dozens of bidders, while small open-market solicitations may have only a few. Monitoring active solicitations and building agency relationships early improves win rates.

Contract Category

Drug Evaluation Government Contracts

10 government contract opportunities classified as Drug Evaluation, spanning federal and state/local solicitations. Updated daily.

9 federal1 SLEDUpdated daily

Federal Opps

Federal contracts

SLED Opps

State, local & education contracts

Forecasts

—

Agency pipeline forecasts

Total

All sources combined

9 federal contract opportunities classified as Drug Evaluation.

SIMULATIONS PLUS GASTROPLUS SOFTWARE LICENSES

Active

AI Summary

The Department of Health and Human Services plans to procure twenty GastroPlus software licenses and additional companion licenses on a sole source basis from Simulations Plus, Inc. This opportunity is a Source Sought notice, and responses are due by August 10, 2026. Interested parties may submit capability statements …

Posted Aug 3, 2026Due Aug 10, 2026Special NoticeSol: 7571TE-NOI-FDA132771

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

FY26 Annual Send Explorer Warehouse and Technical Support

Archived

AI Summary

The FDA's Center for Drug Evaluation and Research seeks a software solution for the nonclinical review of CDISC-SEND submissions, including a Send Explorer Warehouse license and technical support. Interested bidders should refer to the attached Statement of Work for detailed specifications.

Posted Jul 20, 2026Due Jul 24, 2026SolicitationNAICS 513210Sol: FY2026SENDOMAS-IT

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Notice of Ordering Period Extension-Clinical Evaluation of Phenserine Tartrate Extended Controlled Release Tablet

Archived

AI Summary

The National Institutes of Health intends to modify an existing contract to extend the ordering period for clinical evaluation services of Phenserine tartrate in Alzheimer's disease and traumatic brain injury. This modification will allow for the completion of planned task orders related to pharmacokinetic and pharmaco…

Posted Jul 16, 2026Due Jul 30, 2026PresolicitationNAICS 541990No Set aside usedSol: 75N95024D00002

View details→

FDA - INTENT TO SOLE SOURCE MOLECULAR OPERATING ENVIRONMENT

Archived

AI Summary

The FDA intends to award a sole source contract to Chemical Computing Group ULC for the Molecular Operating Environment software, enhancing analytical capabilities for drug evaluations. The contract will span a base year and four option years, focusing on advanced molecular modeling and cheminformatics. Interested part…

Posted Jun 9, 2026Due Jun 16, 2026Combined Synopsis/SolicitationNAICS 513210Sol: 7571TE26Q00038

View details→

DEPARTMENT OF HEALTH AND HUMAN SERVICES

RECURRENT GLIOBLASTOMAS

Archived

AI Summary

The National Institutes of Health is conducting a clinical trial to evaluate the efficacy and safety of LMP744 in patients with recurrent glioblastoma. This study aims to assess progression-free survival and correlate molecular profiles with clinical outcomes. The trial will involve monitoring 40 patients to provide cr…

Posted Mar 31, 2026Due Apr 15, 2026Special NoticeNAICS 5417158(a) Sole Source (FAR 19.8)Sol: NIMH26000869

View details→

DEPARTMENT OF JUSTICE

Cannabinoid Testing

Archived

AI Summary

The Department of Justice, Drug Enforcement Administration is soliciting proposals for the evaluation of the abuse potential of synthetic cannabinoids and phytocannabinoids through in vivo pharmacological studies. This opportunity is classified under NAICS code 541380, focusing on scientific research and development se…

Posted Jan 29, 2026Due Feb 9, 2026SolicitationNAICS 541380No Set aside usedSol: 15DDHQ25Q00000121

View details→

DEPARTMENT OF JUSTICE

Cannabinoid Testing

Archived

AI Summary

Posted Jan 23, 2026Due Feb 9, 2026SolicitationNAICS 541380No Set aside usedSol: 15DDHQ25Q00000121

View details→

DEPARTMENT OF JUSTICE

CANNABINOID TESTING

Archived

AI Summary

The Department of Justice, Drug Enforcement Administration, is soliciting proposals for the evaluation of the abuse potential of synthetic cannabinoids and phytocannabinoids through in vivo pharmacological studies. This opportunity is classified under NAICS code 541380, focusing on scientific research and development s…

Posted Jan 22, 2026Due Feb 9, 2026SolicitationNAICS 541380Sol: 15DDHQ25Q00000121

View details→

DEPARTMENT OF JUSTICE

CANNABINOID TESTING

Archived

AI Summary

The Department of Justice's Drug Enforcement Administration is soliciting proposals for the evaluation of the abuse potential of synthetic cannabinoids and phytocannabinoids through in vivo pharmacological studies. This opportunity is classified under NAICS code 541380, focusing on service provision in drug evaluation.

Posted Jan 9, 2026Due Feb 9, 2026SolicitationNAICS 541380Sol: 15DDHQ25Q00000121

View details→

Drug Evaluation Government Contracts — FAQ

Common questions about finding and winning Drug Evaluation government contracts.

Stop searching. Start winning.

Drug Evaluation Government Contracts

Drug Evaluation Government Contracts — FAQ